Novo Nordisk, the Danish pharmaceutical giant known for diabetes and obesity treatments, announced impressive new clinical trial results in collaboration with United Biotechnology for an experimental obesity drug called UBT251. The mid‑stage trial reported a mean weight loss of up to 19.7% after 24 weeks, significantly outperforming the placebo group, which saw just 2.0% weight…
SAABF analyst rating: Morgan Stanley kept Underweight and raised target to SEK 540 on Feb 23, 2026
TATAELXSI.NS stock falls to INR 4498.00 after hours; analysis of valuation, AI exposure, technicals and Meyka AI forecast
Amazon shares fell in early trading after the company confirmed a 12 billion dollar investment in Louisiana data centers to expand its artificial intelligence and cloud infrastructure. The stock, listed on the NASDAQ under AMZN, saw short term pressure as investors weighed rising capital spending against long term AI growth. Amazon announced that it will…
FRVIA.PA stock trades at €13.43 as Forvia warns 2026 sales decline; earnings due 24 Feb 2026 — outlook and Meyka forecast
Trump Tower Gold Coast moves closer with an A$1.5b Trump Organization deal. Proposed 340m tower in Surfers Paradise could reshape luxury property and tourism in AU.
Intraday update: OBSN.SW stock at CHF0.0012, -76.92% on SIX with 2.35M shares traded; analysis and short-term outlook
4894.T stock fell 33.97% to JPY 7,230.00 on JPX close 24 Feb 2026; high volume and valuation gaps increase short-term risk
Tesla, the US electric vehicle maker, saw its new vehicle registrations in the European Union fall by 17% year‑on‑year in January 2026. According to industry data from the European Automobile Manufacturers’ Association (ACEA), Tesla sold 8,075 cars in the EU during January, down from 9,733 units in the same month last year. This extended a…
0482.HK stock rose 48.19% to HK$0.123 on 24 Feb 2026. Meyka AI analysis, grade and forecast with upside estimates